Literature DB >> 21605859

Impaired expansion of trophoblast spheroids cocultured with endometrial cells overexpressing cellular retinoic acid-binding protein 2.

Jiae Lee1, Jeong Su Oh, Chunghee Cho.   

Abstract

We previously showed that the cellular retinoic acid-binding protein 2 (CRABP2) gene was up-regulated during the implantation window period in the endometrium of patients with unexplained recurrent spontaneous abortion. Here, we report that trophoblast spheroids cocultured with a human endometrial cell line stably overexpressing CRABP2 are defective in expansion and exhibit apoptosis, suggesting that the altered expression level of endometrial CRABP2 is involved in abnormal endometrium-trophoblast interaction, which leads to implantation failure.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21605859     DOI: 10.1016/j.fertnstert.2011.04.065

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Reprogramming of the retinoic acid pathway in decidualizing human endometrial stromal cells.

Authors:  Rie Ozaki; Keiji Kuroda; Yuko Ikemoto; Asako Ochiai; Akemi Matsumoto; Jun Kumakiri; Mari Kitade; Atsuo Itakura; Joanne Muter; Jan J Brosens; Satoru Takeda
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

2.  PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice.

Authors:  Marie Christou-Kent; Zine-Eddine Kherraf; Amir Amiri-Yekta; Emilie Le Blévec; Thomas Karaouzène; Béatrice Conne; Jessica Escoffier; Said Assou; Audrey Guttin; Emeline Lambert; Guillaume Martinez; Magalie Boguenet; Selima Fourati Ben Mustapha; Isabelle Cedrin Durnerin; Lazhar Halouani; Ouafi Marrakchi; Mounir Makni; Habib Latrous; Mahmoud Kharouf; Charles Coutton; Nicolas Thierry-Mieg; Serge Nef; Serge P Bottari; Raoudha Zouari; Jean Paul Issartel; Pierre F Ray; Christophe Arnoult
Journal:  EMBO Mol Med       Date:  2018-05       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.